{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:22:17Z","timestamp":1782127337254,"version":"3.54.5"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,19]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene leading to very long chain fatty acid (VLCFA) accumulation. The disease demonstrates a spectrum of phenotypes including adrenomyeloneuropathy (AMN). We aimed to identify the genetic basis of disease in a patient presenting with AMN features in order to confirm the diagnosis, expand genetic knowledge of ABCD1 mutations, and elucidate potential genotype-phenotype associations to inform management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 29-year-old male presented with a 4-year history of progressive spastic paraplegia, weakness of lower limbs, fecal incontinence, sexual dysfunction, hyperreflexia, and positive Babinski and Chaddock signs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Neuroimaging revealed brain white matter changes and spinal cord thinning. Significantly elevated levels of hexacosanoic acid (C26:0) and tetracosanoic acid (C24:0) suggested very long chain fatty acids (VLCFA) metabolism disruption. Genetic testing identified a novel hemizygous ABCD1 mutation c.249dupC (p.F83fs). These findings confirmed a diagnosis of X-linked ALD with an AMN phenotype.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient received dietary counseling to limit VLCFA intake. Monitoring for adrenal insufficiency and consideration of Lorenzo\u2019s oil were advised. Genetic counseling and testing were offered to at-risk relatives.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>At present, the patient continues to experience progressive paraplegia. Adrenal function remains normal thus far without steroid replacement. Family members have undergone predictive testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case expands the known mutation spectrum of ABCD1-linked X-ALD, providing insight into potential genotype-phenotype correlations. A thoughtful diagnostic approach integrating clinical, biochemical and genetic data facilitated diagnosis. Findings enabled genetic counseling for at-risk relatives regarding this X-linked disorder.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037874","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T18:08:09Z","timestamp":1713550089000},"page":"e37874","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A novel ABCD1 gene mutation causes adrenomyeloneuropathy presenting with spastic paraplegia: A case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0921-1267","authenticated-orcid":false,"given":"Jinxin","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2874-7611","authenticated-orcid":false,"given":"Lei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-9329","authenticated-orcid":false,"given":"Yankun","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0166-2236(98)01319-8","article-title":"The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder.","volume":"22","author":"Dubois-Dalcq","year":"1999","journal-title":"Trends Neurosci"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1212\/WNL.0000000000201374","article-title":"International recommendations for the diagnosis and management of patients with adrenoleukodystrophy: a consensus-based approach.","volume":"99","author":"Engelen","year":"2022","journal-title":"Neurology"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrendo.2016.90","article-title":"Adrenoleukodystrophy \u2013 neuroendocrine pathogenesis and redefinition of natural history.","volume":"12","author":"Kemp","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamaneurol.2020.0019","article-title":"Adrenomyeloneuropathy masquerading as chronic myelitis.","volume":"77","author":"Azar","year":"2020","journal-title":"JAMA Neurol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1212\/WNL.0000000000007755","article-title":"Pearls & Oy-sters: adolescent-onset adrenomyeloneuropathy and arrested cerebral adrenoleukodystrophy.","volume":"93","author":"Lin","year":"2019","journal-title":"Neurology"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000112170","article-title":"Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy.","volume":"13","author":"Moser","year":"1991","journal-title":"Dev Neurosci"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"19269","DOI":"10.1074\/jbc.M112.445445","article-title":"Impaired very long-chain Acyl-CoA \u03b2-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.","volume":"288","author":"Wiesinger","year":"2013","journal-title":"J Biol Chem"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1038\/s41467-022-30974-5","article-title":"Structural basis of substrate recognition and translocation by human very long-chain fatty acid transporter ABCD1.","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2011.05.016","article-title":"X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism.","volume":"104","author":"Wang","year":"2011","journal-title":"Mol Genet Metab"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-022-01280-9","article-title":"Structural insights into substrate recognition and translocation of human peroxisomal ABC transporter ALDP.","volume":"8","author":"Xiong","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/endrev\/bnaa013","article-title":"The changing face of adrenoleukodystrophy.","volume":"41","author":"Zhu","year":"2020","journal-title":"Endocr Rev"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/gim.2016.68","article-title":"Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation.","volume":"19","author":"Kemper","year":"2017","journal-title":"Genet Med"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2007-973526","article-title":"Clinical and genetic aspects of X-linked adrenoleukodystrophy.","volume":"29","author":"G\u00e4rtner","year":"1998","journal-title":"Neuropediatrics"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pediatrneurol.2005.03.006","article-title":"ABCD1 gene mutations in chinese patients with X-linked adrenoleukodystrophy.","volume":"33","author":"Pan","year":"2005","journal-title":"Pediatr Neurol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1023\/A:1022535930009","article-title":"X-Linked adrenoleukodystrophy: genes, mutations, and phenotypes.","volume":"24","author":"Smith","year":"1999","journal-title":"Neurochem Res"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10048-010-0253-6","article-title":"Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes.","volume":"12","author":"Matsukawa","year":"2011","journal-title":"Neurogenetics"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.parkreldis.2019.06.008","article-title":"Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia.","volume":"65","author":"Chen","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1399-0004.2005.00423.x","article-title":"X-linked adrenoleukodystrophy in Spain. Identification of 26 novel mutations in the ABCD1 gene in 80 patients. Improvement of genetic counseling in 162 relative females.","volume":"67","author":"Coll","year":"2005","journal-title":"Clin Genet"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.3390\/ijms24065957","article-title":"Two single nucleotide deletions in the ABCD1 gene causing distinct phenotypes of X-linked adrenoleukodystrophy.","volume":"24","author":"Dohr","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"e1844","DOI":"10.1002\/mgg3.1844","article-title":"Genetic analysis and prenatal diagnosis of 76 Chinese families with X-linked adrenoleukodystrophy.","volume":"10","author":"Liu","year":"2022","journal-title":"Mol Genet Genomic Med"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/jpgm.JPGM_349_17","article-title":"Childhood cerebral X-linked adrenoleukodystrophy with atypical neuroimaging abnormalities and a novel mutation.","volume":"64","author":"Muranjan","year":"2018","journal-title":"J Postgrad Med"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bbadis.2012.03.012","article-title":"X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.","volume":"1822","author":"Kemp","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/humu.1227","article-title":"ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations.","volume":"18","author":"Kemp","year":"2001","journal-title":"Hum Mutat"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1474-4422(22)00495-1","article-title":"Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2\u20133 trial.","volume":"22","author":"K\u00f6hler","year":"2023","journal-title":"Lancet Neurol"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.61.2.181","article-title":"Nerve conduction studies in adrenomyeloneuropathy.","volume":"61","author":"Chaudhry","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/brain\/aww068","article-title":"Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy: in vivo assessment of structural changes.","volume":"139","author":"Castellano","year":"2016","journal-title":"Brain"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/brain\/awt189","article-title":"Adrenoleukodystrophy and the mitochondrial connection: clues for supplementing Lorenzo\u2019s oil.","volume":"136","author":"Moraes","year":"2013","journal-title":"Brain"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"e0238796","DOI":"10.1371\/journal.pone.0238796","article-title":"Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders. Metodiev MD, ed.","volume":"15","author":"Stradomska","year":"2020","journal-title":"PLoS One"},{"key":"R31-20250503","first-page":"753","article-title":"Is subclinical adrenal failure in adrenoleukodystrophy\/adrenomyeloneuropathy reversible?","volume":"34","author":"Cappa","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.bbamcr.2006.07.010","article-title":"X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.","volume":"1763","author":"Berger","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2009.11.005","article-title":"Head trauma can initiate the onset of adreno-leukodystrophy.","volume":"290","author":"Raymond","year":"2010","journal-title":"J Neurol Sci"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/ajmg.1320440509","article-title":"Predictions of a 2-locus model for disease heterogeneity: application to adrenoleukodystrophy.","volume":"44","author":"Maestri","year":"1992","journal-title":"Am J Med Genet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:10:50Z","timestamp":1746317450000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":34,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037874","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]}}}